New developments in bone formation

Current Opinion in Nephrology and Hypertension

Volumn 7, Issue 4, 1998, Pages 363-366

  Owen, Michael J ^a   Karsenty, Gerard ^b  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

CLEIDOCRANIAL DYSPLASIA; GENE ISOLATION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; OSSIFICATION; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION;

ANIMALS; BONE DEVELOPMENT; CELL DIVISION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; HUMANS; NEOPLASM PROTEINS; OSTEOBLASTS; TRANSCRIPTION FACTORS;

EID: 0031829460     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199807000-00003     Document Type: Review

References (19)

1. Hogan BLM. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes and Dev 1996; 10:1580-1594.
2. Rhodes SJ, DiMattia GE, Rosenfeld MG. Transcriptional mechanisms in anterior pituitary cell differentiation. Curr Opin Genet Dev 1994; 4:709-717.
3. Orkin SH. Transcription factors and hematopoietic development. J Biol Chem 1995; 270:4955-4958.
4. Kuo CJ, Conley PB, Chen L, Sladek FM, Darnell JE Jr, Crabtree GR. A transcriptional hierarchy involved in mammalian cell-type specification. Nature 1992; 355:457-461.
5. Molkentin JD, Olson EN. Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc Natl Acad Sci U S A 1996; 93:9366-9373.
6. Spiegelman BM, Flier JS. Adipogenesis and obesity: rounding out the big picture. Cell 1996; 87:377-389.
7. Ducy P, Karsenty G. Two distinct osteoblast-specific cis-acting elements • control expression of a mouse osteocalcin gene. Mol Cell Biol 1995; 15:1858-1869. This paper identifies for the first time a Cbfa binding sequence as a true osteoblast-specific cis-acting element.
8. Geoffroy V, Ducy P, Karsenty G. A PEBP2/AML-1 -related factor increases • osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element. J Biol Chem 1995; 270:30973-30979. This paper present the first evidence that a runt-related protein binds to the osteocalcin promoter, and that co-transfection with a runt protein can increase its transcriptional activity.
9. Merriman HL, van Wijnen AJ, Hiebert S, Bidwell JP, Fey E, Lian J, Stein J, • Stein GS. The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBP2/Runt domain transcription factor family: interactions with the osteocalcin gene promoter. Biochemistry 1995; 34:13125-13132. Same as [8].
10. Ito Y, Bae S-C. The runt domain transcription factor PEBP2/CBF, and its involvment in human leukemia. In Oncogenes as transcriptional regulators. Vol. 2: Cell cycle regulators and chromosomal transclocation. M Yaniv and J Ghysdael (editors). Basel, Switzerland. 1997, pp. 107-132.
11. Gergen JP, Wieschaus E. The localized requirements for a gene affecting segmentation in Drosophila: analysis of larvae mosaic for runt. Dev Biol 1985, 109:321-335.
12. Kagoshima H, Shigesada K, Satake M, Ito Y, Miyoshi H, Ohki M, Pepling M, Gergen P. The Runt domain identifies a new family of heteromeric transcriptional regulators. Trends in Genet 1993; 9:338-341.
13. Satake M, Nomura S, Yamagushi-lwai Y, Takahama Y, Hashimoto Y, Niki M, Kitamura Y, Ito Y. Expression of the runt domain-encoding PEBP2α genes in T cells during thymic development. Mol Cell Biol 1995; 15:1662-1670.
14. Ducy P, Zhang R, Geoffroy V, Ridall A, Karsenty G. Osf2/Cbfa1: •• a transcriptional activator of osteoblast differentiation. Cell 1997; 89:747-754. Cloning of Osf2/Cbfa1 cDNA and molecular evidence that it acts as an osteoblast-specific activator of transcription. This paper shows the restriction of Osf2/Cbfa1 expression to the osteoblastic lineage and its ability to bind to the promoter and activate transcription of the principal osteoblast-specific genes in osteoblastic as well as in non-osteoblastic cells.
15. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, •• Stamp GWH, Beddington RSP, Mundlos S, Olsen BR, Selby PB, Owen MJ. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997; 89:765-771. Targeted disruption of the Cbfa1 gene in mice. This paper shows the requirement of Cbfa1 for osteoblast differentiation during embryogenesis. It also establishes the genetic link between Cbfa1 and the CCD phenotype in mice.
16. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu •• Y, Bronson RT, Gao Y-H, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997; 89:755-764. Targeted disruption of the Cbfa1 gene in mice. This study shows the requirement of Cbfa1 for osteoblast differentiation and osteoblast-specific gene expression during embryogenesis.
17. Sillence DO, Ritchie HE, Selby PB. Animal model: Skeletal abnormalities in mice with cleidocranial dysplasia Am J Med Genet 1987; 27:75-85.
18. Lee B, Thirunavukkarasu K, Zhou L, Pastore L, Baldini A, Geoffroy V, Ducy P, •• Karsenty G. Missense mutations abolishing DNA binding OSF2/CBFA1 in patients affected with cleidocranial dysplasia. Nature Genet 1997; 16:307-311. Characterization of missense mutations in the DMA-binding domain encoding region of the CBFA1 gene in Cleidocranial dysplasia patients.
19. Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, Albright S, •• Lindhout D, Cole WG, Henn W, Knoll JHM, Owen MJ, Mertelsmann R, Zabel BU, Olsen BR. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 1997; 89:773-779. Characterization of deletions, stop codon and insertion mutations in the CBFA1 gene of Cleidocranial dysplasia patients. This paper is particularly important because it shows that CCD is caused by haploinsufficiency